References
- Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER cancer statistics review. Bethesda (MD): National Cancer Institute; 1975–2017. [accessed 2020 Sep 12]. https://seer.cancer.gov/csr/1975_2017/
- Suurmeijer AJH, Bruijn D, Kessel A, Miettinen M. Synovial sarcoma. In: Fletcher CDM, Hogendoorn P, Mertens F, editors. WHO classification of tumors of soft tissue and bone. 4th ed. Lyon, France: IARC Press; 2013. p. 213–215.
- Shi W, Indelicato DJ, Morris CG, Scarborough MT, Gibbs CP, Zlotecki RA. Long-term treatment outcomes for patients with synovial sarcoma: a 40-year experience at the University of Florida. Ame J Clin Oncol. 2013;36(1):83–88. doi:https://doi.org/10.1097/COC.0b013e31823fe450.
- Keel SB, Bacha E, Mark EJ, Nielsen GP, Rosenberg AE. Primary pulmonary sarcoma: a clinicopathologic study of 26 cases. Mod Pathol. 1999;12(12):1124–1131.
- Litzky LA. Pulmonary sarcomatous tumors. Arch Pathol Lab Med. 2008;132(7):1104–1117. doi:https://doi.org/10.5858/2008-132-1104-PST.
- Doyle LA. Surgical pathology of sarcomas. In: McManus LM, Mitchell RN, editors. Pathobiology of human disease. San Diego (CA): Academic Press; 2014. p. 3546–3562.
- Janssen JP, Mulder JJ, Wagenaar SS, Elbers HR, van den Bosch JM. Primary sarcoma of the lung: a clinical study with long-term follow-up. Ann Thorac Surg. 1994;58(4):1151–1155. doi:https://doi.org/10.1016/0003-4975(94)90476-6.
- Spraker MB, Bair E, Bair R, Connell PP, Mahmood U, Koshy M. An analysis of patient characteristics and clinical outcomes in primary pulmonary sarcoma. J Thorac Oncol. 2013;8(2):147–151. doi:https://doi.org/10.1097/JTO.0b013e318277401f.
- Zeren H, Moran CA, Suster S, Fishback NF, Koss MN. Primary pulmonary sarcomas with features of monophasic synovial sarcoma: a clinicopathological, immunohistochemical, and ultrastructural study of 25 cases. Hum Pathol. 1995;26(5):474–480. doi:https://doi.org/10.1016/0046-8177(95)90242-2.
- Dacic S, Franks TJ, Ladanyi M, et al. Synovial sarcoma. In: Travis WD, Brambilla E, Burke AP, editors. WHO classification of tumours of the lung, pleura, thymus and heart. World health organization classification of tumours. 4th ed. Lyon, France: International Agency for Research on Cancer; 2015. p. 127–128.
- Wick MR, Leslie KO, Stoler MH. Sarcomas and sarcomatoid neoplasms of the lungs and pleural surfaces. In: Leslie KO, Wick MR, editors. Practical pulmonary pathology: a diagnostic approach. 3rd ed. Amsterdam, Netherlands: Elsevier; 2018. p. 467–526.e3.
- Roy P, Das A, Sarkar A, Dwari A, Datta S. A primary synovial sarcoma of lung. North Am J Med Sci. 2012;4(5):241–243. doi:https://doi.org/10.4103/1947-2714.9591.
- Etienne-Mastroianni B, Falchero L, Chalabreysse L, Loire R, Ranchère D, Souquet PJ, Cordier JF. Primary sarcomas of the lung: a clinicopathologic study of 12 cases. Lung Cancer (Amsterdam, Netherlands). 2002;38(3):283–289. doi:https://doi.org/10.1016/S0169-5002(02)00303-3.
- Lan T, Chen H, Xiong B, Zhou T, Peng R, Chen M, et al. Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China. Diagn Pathol. 2016;11(1):62. doi:https://doi.org/10.1186/s13000-016-0513-3.
- Frazier AA, Franks TJ, Pugatch RD, Galvin JR. Pleuropulmonary synovial sarcoma. RadioGraphics. 2006;26(3):923–940. doi:https://doi.org/10.1148/rg.263055211.
- Polverosi R, Muzzio PC, Panunzio A, Pasquotti G, Schiavon M, Rea F. Synovial sarcoma: CT imaging of a rare primary malignant tumour of the thorax. La Radiol Med. 2011;116(6):868–875. doi:https://doi.org/10.1007/s11547-011-0692-7.
- Hartel PH, Fanburg-Smith JC, Frazier AA, Galvin JR, Lichy JH, Shilo K, Franks TJ. Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Mod Pathol. 2007;20(7):760–769. doi:https://doi.org/10.1038/modpathol.3800795.
- Esaka EJ, Celebrezze JU, Golde SH, Chiossi G, Thomas RL. Pulmonary synovial sarcoma presenting as a pneumothorax during pregnancy. Obstet Gynecol. 2008;111(2 Pt 2):555–558. doi:https://doi.org/10.1097/01.AOG.0000286769.70432.de.
- Cummings NM, Desai S, Thway K, Stewart S, Hill DA, Priest JR, et al. Cystic primary pulmonary synovial sarcoma presenting as recurrent pneumothorax: report of 4 cases. Am J Surg Pathol. 2010;34(8):1176–1179. doi:https://doi.org/10.1097/PAS.0b013e3181e85c87.
- Johnson ED, Downs-Kelly E, Bull DA, Gulbahce HE. Primary cystic pleuropulmonary synovial sarcoma presenting as recurrent pneumothorax. Case Rep Oncol. 2017;10(2):660–665. doi:https://doi.org/10.1159/000478845.
- Estors M, Rinaldi P, Gaspar C, Sánchez F, Esturi R, Galbis JM. Pleuropulmonary synovial sarcoma presenting as recurrent pneumothorax. Rev Patol Respirat. 2012;15(2):61–63. doi:https://doi.org/10.1016/S1576-9895(12)70142-X.
- Egger JF, Coindre JM, Benhattar J, Coucke P, Guillou L. Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases. Mod Pathol. 2002;15(9):998–1004. doi:https://doi.org/10.1097/01.MP.0000026616.41545.FF.
- Bode-Lesniewska B, Hodler J, von Hochstetter A, Guillou L, Exner U, Caduff R. Late solitary bone metastasis of a primary pulmonary synovial sarcoma with SYT-SSX1 translocation type: case report with a long follow-up. Virchows Arch. 2005;446(3):310–315. doi:https://doi.org/10.1007/s00428-004-1174-2.
- Bégueret H, Galateau-Salle F, Guillou L, Chetaille B, Brambilla E, Vignaud JM, et al. Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French sarcoma group and the Mesopath Group. Am J Surg Pathol. 2005;29(3):339–346. doi:https://doi.org/10.1097/01.pas.0000147401.95391.9a.
- Singhal S, Prajapat D, Sharma R, Talwar D. Primary pulmonary synovial sarcoma: is it worth all the hard work? J Assoc Chest Phys. 2019;7(1):29–34. doi:https://doi.org/10.4103/jacp.jacp_15_18.
- Bergh P, Meis-Kindblom JM, Gherlinzoni F, Berlin O, Bacchini P, Bertoni F, et al. Synovial sarcoma: identification of low and high risk groups. Cancer. 1999;85(12):2596–2607. doi:https://doi.org/10.1002/(SICI)1097-0142(19990615)85:12<2596::AID-CNCR16>3.0.CO;2-K.
- Italiano A, Penel N, Robin YM, Bui B, Le Cesne A, Piperno-Neumann S, et al. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. Ann Oncol. 2009;20(3):425–430. doi:https://doi.org/10.1093/annonc/mdn678.
- Deshmukh R, Mankin HJ, Singer S. Synovial sarcoma: the importance of size and location for survival. Clin Orthop Relat Res. 2004;419:155–161. doi:https://doi.org/10.1097/00003086-200402000-00025.
- Trassard M, Le Doussal V, Hacène K, Terrier P, Ranchère D, Guillou L, et al. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol. 2001;19(2):525–534. doi:https://doi.org/10.1200/JCO.2001.19.2.525.
- Panigrahi M, Pradhan G, Sahoo N, Mishra P, Patra S, Mohapatra P. Primary pulmonary synovial sarcoma: a reappraisal. J Cancer Res Ther. 2018;14(3):481–489. doi:https://doi.org/10.4103/0973-1482.204883.
- Al-Ani Z, Naqvi J, Oh TC. Primary pleuropulmonary synovial sarcoma mimicking a carcinoid tumor: case report and literature review. Radiol Case Rep. 2016;11(2):45–49. doi:https://doi.org/10.1016/j.radcr.2016.02.007.
- Essary LR, Vargas SO, Fletcher CD. Primary pleuropulmonary synovial sarcoma: reappraisal of a recently described anatomic subset. Cancer. 2002;94(2):459–469. doi:https://doi.org/10.1002/cncr.10188.
- Okamoto S, Hisaoka M, Daa T, Hatakeyama K, Iwamasa T, Hashimoto H. Primary pulmonary synovial sarcoma: a clinicopathologic, immunohistochemical, and molecular study of 11 cases. Hum Pathol. 2004;35(7):850–856. doi:https://doi.org/10.1016/j.humpath.2004.02.011.
- Goldblum J, Weiss S, Folpe AL. Enzinger and Weiss’s soft tissue tumors. 7th ed. Amsterdam, Netherlands: Elsevier; 2019.
- Meis-Kindblom JM, Stenman G, Kindblom LG. Differential diagnosis of small round cell tumors. Semin Diagn Pathol. 1996;13(3):213–241.
- Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol. 1998;22(6):673–682. doi:https://doi.org/10.1097/00000478-199806000-00004.
- Miettinen M. Keratin subsets in spindle cell sarcomas. Keratins are widespread but synovial sarcoma contains a distinctive keratin polypeptide pattern and desmoplakins. Am J Pathol. 1991;138(2):505–513.
- Smith TA, Machen SK, Fisher C, Goldblum JR. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor. Am J Clin Pathol. 1999;112(5):641–648. doi:https://doi.org/10.1093/ajcp/112.5.641.
- Miettinen M, Limon J, Niezabitowski A, Lasota J. Calretinin and other mesothelioma markers in synovial sarcoma: analysis of antigenic similarities and differences with malignant mesothelioma. Am J Surg Pathol. 2001;25(5):610–617. doi:https://doi.org/10.1097/00000478-200105000-00007.
- Arnold MA, Arnold CA, Li G, Chae U, El-Etriby R, Lee CC, Tsokos M. A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics. Hum Pathol. 2013;44(5):881–887. doi:https://doi.org/10.1016/j.humpath.2012.08.014.
- Baranov E, McBride MJ, Bellizzi AM, Ligon AH, Fletcher CDM, Kadoch C, Hornick JL. A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma. Am J Surg Pathol. 2020;44(7):922–933. doi:https://doi.org/10.1097/PAS.0000000000001447.
- Guccion JG, Rosen SH. Bronchopulmonary leiomyosarcoma and fibrosarcoma. A study of 32 cases and review of the literature. Cancer. 1972;30:836–847. doi:https://doi.org/10.1002/1097-0142(197209)30:3 < 836::AID-CNCR2820300335 > 3.0.CO;2-C.
- Logrono R, Filipowicz EA, Eyzaguirre EJ, Sawh RN. Diagnosis of primary fibrosarcoma of the lung by fine-needle aspiration and core biopsy. Arch Pathol Lab Med. 1999;123(8):731–735. doi:https://doi.org/10.5858/1999-123-0731-DOPFOT.
- Ali SZ, Hoon V, Hoda S, Heelan R, Zakowski MF. Solitary fibrous tumor. A cytologic-histologic study with clinical, radiologic, and immunohistochemical correlations. Cancer. 1997;81(2):116–121. doi:https://doi.org/10.1002/(SICI)1097-0142(19970425)81:2<116::AID-CNCR5>3.0.CO;2-Q.
- Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014;27(3):390–395. doi:https://doi.org/10.1038/modpathol.2013.164.
- Gaertner E, Zeren EH, Fleming MV, Colby TV, Travis WD. Biphasic synovial sarcomas arising in the pleural cavity. A clinicopathologic study of five cases. Am J Surg Pathol. 1996;20(1):36–45. doi:https://doi.org/10.1097/00000478-199601000-00004.
- Grondin SC, Sugarbaker DJ. Malignant mesothelioma of the pleural space. Oncology (Williston Park, NY). 1999;13(7):919–926. Juldiscussion 926, 931–932.
- Walz R, Koch HK. Malignant pleural mesothelioma: some aspects of epidemiology, differential diagnosis and prognosis. Histological and immunohistochemical evaluation and follow-up of mesotheliomas diagnosed from 1964 to January 1985. Pathol Res Pract. 1990;186(1):124–134. doi:https://doi.org/10.1016/S0344-0338(11)81020-4.
- Churg A, Cagle P, Roggli B. Tumors of the serosal membranes. AFIP atlas of tumor pathology, 4th series, fascicle 10. Washington (DC): American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology; 2006.
- Yang K, Lui W-O, Xie Y, Zhang A, Skytting B, Mandahl N, et al. Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. Oncogene. 2002;21(26):4181–4190. doi:https://doi.org/10.1038/sj.onc.1205569.
- Amary MF, Berisha F, Bernardi Fdel C, Herbert A, James M, Reis-Filho JS, et al. Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma. Mod Pathol. 2007;20(4):482–496. doi:https://doi.org/10.1038/modpathol.3800761.
- Perret R, Velasco V, Le Guellec S, Coindre J-M, Le Loarer F. The SS18-SSX antibody has perfect specificity for the SS18-SSX fusion protein: a validation study of 609 neoplasms including 2 unclassified tumors with: SS18: -non-: SSX: fusions. Am J Surg Pathol. 2021;45(4):582–584. doi:https://doi.org/10.1097/PAS.0000000000001628.
- Mirzoyan M, Muslimani A, Setrakian S, Swedeh M, Daw HA. Primary pleuropulmonary synovial sarcoma. Clin Lung Cancer. 2008;9(5):257–261. doi:https://doi.org/10.3816/CLC.2008.n.040.
- Gladish GW, Sabloff BM, Munden RF, Truong MT, Erasmus JJ, Chasen MH. Primary thoracic sarcomas. Radiographics. 2002;22(3):621–637. doi:https://doi.org/10.1148/radiographics.22.3.g02ma17621.
- Kalpathi K, Linga VG, Digumarti R, Gundeti S, Uppin S. Primary pleuropulmonary synovial sarcoma: a report of two cases and review of literature. South Asian J Cancer. 2013;2(4):231. doi:https://doi.org/10.4103/2278-330X.119933.
- Ward RC, Birnbaum AE, Aswad BI, Healey TT. Solitary pulmonary nodule: pleuropulmonary synovial sarcoma. Rhode Island Med J. 2013;97(5):40–43.
- Zhang WD, Guan YB, Chen YF, Li CX. CT imaging of primary pleuropulmonary synovial sarcoma. Clin Radiol. 2012;67(9):884–888. doi:https://doi.org/10.1016/j.crad.2012.02.009.
- Chokesuwattanaskul W, Terrell J, Jenkins LA. Monophasic synovial sarcoma presenting as mitral valve obstruction. Tex Heart Inst J. 2010;37(4):472–475.
- Do YW, Lee Y, Kim GJ, Cho JY, Lee DH. Complete resection of primary pulmonary malignancy extending into the left atrium via the left pulmonary vein using cardiopulmonary bypass and single incision: a case series. Thorac Cancer. 2019;10(5):1260–1262. doi:https://doi.org/10.1111/1759-7714.13028.
- Khan SG, Jaber FI, Matejak BP, Newman T, Amin HH. Primary monophasic synovial sarcoma of the pleura. Chest. 2004;126(4):981S. doi:https://doi.org/10.1016/S0012-3692(16)47126-6.
- Tailor J, Roy PG, Bowker C, Lakhoo K. Primary pleural synovial sarcoma presenting as a multiloculated cyst in an adolescent. Pediatr Surg Int. 2008;24(5):597–599. doi:https://doi.org/10.1007/s00383-007-2078-4.
- Silva RG, Gross JL, Silva RA, Haddad FJ, Younes RN, Cruz VM, Avertano-Rocha AB. Primary monophasic synovial sarcoma of the pleura: neoadjuvant chemotherapy followed by complete resection. Thoracic Cancer. 2010;1(3):95–101. doi:https://doi.org/10.1111/j.1759-7714.2010.00019.x.
- Yao H, Hu Z, Lin H, Shi H. Primary pulmonary synovial sarcoma with multiple pleural metastases: a case report and review of the literature. Chinese-German J Clin Oncol. 2011;10(9):547. doi:https://doi.org/10.1007/s10330-011-0844-1.
- Değirmencioğlu S, Değirmencioğlu B, Yalçin N, Öztürk E. Primary pulmonary biphasic synovial sarcoma: a case report. Anatol J Clin Investig. 2010;3.
- Kambo JS, Richardson B, Ionescu DN, Tucker T, Kraushaar G. Primary pulmonary synovial sarcoma: a case report with unique and impressive computed tomography findings. Can Respir J. 2015;22(1):e1–3. doi:https://doi.org/10.1155/2015/231043.
- Pereira G, Pires A, Barbosa S, Cotter J. Pulmonary synovial sarcoma: an unpleasant surprise. Eur J Case Rep Intern Med. 2021;8(3):002149–002149. doi:https://doi.org/10.12890/2021_002149.
- Vlenterie M, Jones RL, van der Graaf WT. Synovial sarcoma diagnosis and management in the era of targeted therapies. Curr Opin Oncol. 2015;27(4):316–322. doi:https://doi.org/10.1097/CCO.0000000000000198.
- Desar IME, Fleuren EDG, van der Graaf WTA. Systemic treatment for adults with synovial sarcoma. Curr Treat Options Oncol. 2018;19(2):13. doi:https://doi.org/10.1007/s11864-018-0525-1.
- Judson I, Verweij J, Gelderblom H, Hartmann JT, Schöffski P, Blay JY, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol. 2014;15(4):415–423. doi:https://doi.org/10.1016/S1470-2045(14)70063-4.
- Edmonson JH, Ryan LM, Falkson CI, Hicks DG, Blum RH. Phase II study of ifosfamide + doxorubicin in patients with advanced synovial sarcomas (E1793): a trial of the eastern cooperative oncology group. Sarcoma. 2003;7(1):9–11. doi:https://doi.org/10.1080/1357714031000114156.
- Nielsen TO, Poulin NM, Ladanyi M. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy. Cancer Discov. 2015;5(2):124–134. doi:https://doi.org/10.1158/2159-8290.CD-14-1246.
- Ray-Coquard I, Le Cesne A, Whelan JS, Schoffski P, Bui BN, Verweij J, et al. A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens. Oncologist. 2008;13(4):467–473. doi:https://doi.org/10.1634/theoncologist.2008-0065.
- Maki RG, D'Adamo DR, Keohan ML, Saulle M, Schuetze SM, Undevia SD, et al. Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol. 2009;27(19):3133–3140. doi:https://doi.org/10.1200/JCO.2008.20.4495.
- Kotecki N, Brodowicz T, Le Cesne A, Le Deley MC, Wallet J, Italiano A, et al. Post-cross-over activity of regorafenib (RE) in soft tissue sarcoma: analysis from the REGOSARC trial. J Clin Oncol. 2017;35:11052–11052. doi:https://doi.org/10.1200/JCO.2017.35.15_suppl.11052.
- Kawaguchi S, Tsukahara T, Ida K, Kimura S, Murase M, Kano M, et al. SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group. Cancer Sci. 2012;103(9):1625–1630. doi:https://doi.org/10.1111/j.1349-7006.2012.02370.x.
- Jones KB, Su L, Jin H, Lenz C, Randall RL, Underhill TM, et al. SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas. Oncogene. 2013;32(18):2365–2371. 2375.e1–5. doi:https://doi.org/10.1038/onc.2012.247.
- Miwa S, Nishida H, Tanzawa Y, Takeuchi A, Hayashi K, Yamamoto N, et al. Phase 1/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma. Cancer. 2017;123(9):1576–1584. doi:https://doi.org/10.1002/cncr.30606.
- Robbins PF, Kassim SH, Tran TL, Crystal JS, Morgan RA, Feldman SA, et al. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response. Clin Cancer Res. 2015;21(5):1019–1027. doi:https://doi.org/10.1158/1078-0432.CCR-14-2708.
- Fukukawa C, Hanaoka H, Nagayama S, Tsunoda T, Toguchida J, Endo K, et al. Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci. 2008;99(2):432–440. doi:https://doi.org/10.1111/j.1349-7006.2007.00701.x.
- Schoffski P, Agulnik M, Stacchiotti S, Davis LE, Villalobos VM, Italiano A, et al. Phase 2 multicenter study of the EZH2 inhibitor tazemetostat in adults with synovial sarcoma (NCT02601950). J Clin Oncol. 2017;35(15):11057–11057. doi:https://doi.org/10.1200/JCO.2017.35.15_suppl.11057.
- Wang S, Song R, Sun T, Hou B, Hong G, Mallampati S, et al. Survival changes in patients with synovial sarcoma, 1983–2012. J Cancer. 2017;8(10):1759–1768. doi:https://doi.org/10.7150/jca.17349.
- Jiang J, Zhou J, Ding W. Primary pulmonary synovial sarcoma, a rare primary lung neoplasm: two case reports and review of the current literature. Respirology (Carlton, Vic). 2008;13(5):748–750. doi:https://doi.org/10.1111/j.1440-1843.2008.01317.x.